SCHEMBL8774775

SCHEMBL8774775

COc1ccc(F)c(-c2nc(O)c([N+](=O)[O-])c(O)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH2 P48735 1/20 0.44
NPC1 O15118 5/20 0.42
AMY1A P0DUB6 1/20 0.41
KMT2A Q03164 3/20 0.41
RAB9A P51151 3/20 0.41
MEN1 O00255 2/20 0.41
ABCB1 P08183 1/20 0.40
ABCC1 P33527 1/20 0.40
GRK6 P43250 1/20 0.40
MAPT P10636 5/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 2/20 0.38
HPGD P15428 1/20 0.38
GFER P55789 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
EIF4E P06730 1/20 0.38
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8774927 0.84 ALDH1A1 (0.44) IDH2NPC1AMY1AKMT2ARAB9A
SCHEMBL8774866 0.77 IDH2 (0.51) IDH2NPC1AMY1AKMT2ARAB9A
SCHEMBL23004696 0.76 KMT2A (0.39) NPC1AMY1AKMT2ARAB9AMEN1
SCHEMBL7350863 0.73 HSP90AA1 (0.42) NPC1AMY1ARAB9AGRK6MAPT
SCHEMBL8845427 0.72 IDH2 (0.41) IDH2AMY1AKMT2AMEN1MAPT
SCHEMBL6520 0.69 TDP1 (0.58) NPC1AMY1AKMT2ARAB9AMEN1
SCHEMBL29744326 0.69 ALDH1A1 (0.56) NPC1KMT2ARAB9AMEN1ABCB1
SCHEMBL29445159 0.69 TDP1 (0.58) NPC1AMY1AKMT2ARAB9AMEN1
SCHEMBL3192746 0.69 ALDH1A1 (0.56) NPC1KMT2ARAB9AMEN1ABCB1
SCHEMBL2314995 0.68 VCAM1 (0.50) KMT2ARAB9AMEN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5688654-A GAMMA-AMINOBUTYRIC ACID NEUROGEN CORPORATION (US) 1997-11-18 US disclosed
EP-0639275-B1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES NEUROGEN CORP (US) 1997-09-17 EP disclosed
US-5597920-A Gabaa receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to gabaa receptor subtypes NEUROGEN CORPORATION (US) 1997-01-28 US disclosed
EP-0639275-A1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES. NEUROGEN CORP (US) 1995-02-22 EP disclosed
WO-1993022681-A1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES NEUROGEN CORPORATION (US) 1993-11-11 WO disclosed